Pathogenesis of Alveolar Osteitis (Dry Socket)

Exam Tip: When asked about the role of hormones in dry socket, remember that estrogen (found in oral contraceptives) enhances serum fibrinolytic activity, which increases the incidence of clot destruction.

The Pathogenesis of Clot Destruction

The central event in the development of these diseases is the destruction of the blood clot. Once the clot is lost or disintegrated, the socket is left open, exposing the underlying bone to the oral environment.

Enzymatic Mechanisms

There are two primary enzymatic pathways believed to contribute to this destruction:

1. Bacterial Proteolytic Enzymes: Bacteria present in the mouth release enzymes that can break down the protein structure of the clot.
2. Local Fibrinolytic Enzymes: This is considered the more widely accepted mechanism. The alveolar bone and surrounding soft tissues contain high levels of fibrinolytic activators, most notably plasmin. When bone is traumatized during extraction, these activators are released, leading to the rapid breakdown of the fibrin meshwork in the clot.

Progression to Necrosis and Pain

Once the clot is destroyed, a cascade of biological degradation begins, leading to the clinical symptoms of alveolar osteitis.

Bone Necrosis and Bacterial Proliferation

The loss of the clot leaves an open socket where food debris and bacteria accumulate. This debris comes into direct contact with the bone, causing the bone—specifically the lamina dura—to become necrotic.

This necrotic bone acts as a shield for bacteria; because the bone is dead, leukocytes (white blood cells) are unable to penetrate the necrotic tissue to reach and fight the infection. Consequently, bacterial proliferation occurs freely within the socket.

Bone Degradation and Healing

As the body attempts to manage the dead tissue, the following processes occur:

• Sequestra Formation: The dead bone gradually separates from the living bone, forming small fragments known as sequestra.
• Granulation Tissue: The separation of dead bone is mediated by granulation tissue, which eventually facilitates healing from the base and walls of the socket.
• Osteoclast Activity: Osteoclasts are involved in the degradation and remodeling of the damaged bone during this phase.

The Mechanism of Neuralgic Pain

The hallmark of this condition is severe, radiating, or neuralgic pain. This pain is driven by the chemical mediator kinin.

The biochemical pathway is as follows:

1. Trauma and inflammation trigger the release of plasmin in the alveolar bone marrow.
2. Plasmin assists in the conversion of kallikreins into kinins.
3. Kinins directly activate local nerve endings, which may already be sensitized by other inflammatory mediators.

Thus, the dual presence of a disintegrated blood clot and intense neuralgic pain can be biochemically linked to the activity of plasmin and the subsequent formation of kinins.